This non-apoptotic mechanism is particularly relevant for therapeutic strategies targeting cell cycle progression in cancer cells, where CDK4 overexpression has been linked to poor prognosis and increased cell proliferation in breast cancer [25,26,27]. This evidence concerns the gene CDK4 and breast carcinoma.